The treatment and natural course of peripheral and central vertigo
Background Recent studies have extended our understanding of the pathophysiology,
natural course, and treatment of vestibular vertigo. The relative frequency of the different …
natural course, and treatment of vestibular vertigo. The relative frequency of the different …
Guideline clinical nutrition in patients with stroke
R Wirth, C Smoliner, M Jäger, T Warnecke… - … & translational stroke …, 2013 - Springer
Stroke is regularly accompanied by dysphagia and other factors associated with decreased
nutritional intake. Dysphagia with aspiration pneumonia and insufficient nutritional intake …
nutritional intake. Dysphagia with aspiration pneumonia and insufficient nutritional intake …
Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind …
Background Non-medical, non-pharmacological and pharmacological treatments are
recommended for the prevention of migraine. The purpose of this randomized double-blind …
recommended for the prevention of migraine. The purpose of this randomized double-blind …
Affective and cognitive theory of mind in patients with Parkinson's disease
ME Bodden, B Mollenhauer, C Trenkwalder… - Parkinsonism & related …, 2010 - Elsevier
Theory of Mind (ToM), which is the ability to infer other people's mental states such as beliefs
or desires, is an important prerequisite for social interaction. Affective and cognitive …
or desires, is an important prerequisite for social interaction. Affective and cognitive …
Depression in epilepsy: a critical review from a clinical perspective
C Hoppe, CE Elger - Nature Reviews Neurology, 2011 - nature.com
Depression is a serious and frequent comorbidity of epilepsy and other neurological
conditions. Here, we review recent studies on the relationship between epilepsy and …
conditions. Here, we review recent studies on the relationship between epilepsy and …
Do we need to rethink the epidemiology and healthcare utilization of Parkinson's disease in Germany?
S Heinzel, D Berg, S Binder, G Ebersbach… - Frontiers in …, 2018 - frontiersin.org
Epidemiological aspects of Parkinson's disease (PD), co-occurring diseases and medical
healthcare utilization of PD patients are still largely elusive. Based on claims data of 3.7 …
healthcare utilization of PD patients are still largely elusive. Based on claims data of 3.7 …
Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list.
E Mann, B Böhmdorfer, T Frühwald… - Wiener Klinische …, 2012 - search.ebscohost.com
Background: The practice of inappropriate medication and drug prescription is a major risk
factor for adverse drug reactions in geriatric patients and increases the individual, as well as …
factor for adverse drug reactions in geriatric patients and increases the individual, as well as …
Patients' expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach
F Maier, CJ Lewis, N Horstkoetter, C Eggers… - Journal of Neurology …, 2013 - jnnp.bmj.com
Objective To study patients' expectations of subthalamic deep brain stimulation (STN-DBS)
and their subjective perceived outcome, by using qualitative and quantitative methods in …
and their subjective perceived outcome, by using qualitative and quantitative methods in …
Patient-centered integrated healthcare improves quality of life in Parkinson's disease patients: a randomized controlled trial
Introduction Improving quality of life (QoL) is a key issue when dealing with Parkinson's
disease (PD). Integrative care shows potential to achieve improvements in QoL. Here, we …
disease (PD). Integrative care shows potential to achieve improvements in QoL. Here, we …
OCT1 mediates hepatic uptake of sumatriptan and loss‐of‐function OCT1 polymorphisms affect sumatriptan pharmacokinetics
J Matthaei, D Kuron, F Faltraco, T Knoch… - Clinical …, 2016 - Wiley Online Library
The low bioavailability of the anti‐migraine drug sumatriptan is partially caused by first‐pass
hepatic metabolism. In this study, we analyzed the impact of the hepatic organic cation …
hepatic metabolism. In this study, we analyzed the impact of the hepatic organic cation …